Crozet BioPharma (Crozet) is a Contract Product Development Organization specializing in strategies to streamline and accelerate advanced development of biological products for prevention and treatment of infectious diseases, cancer and allergies. Crozet’s unique, industry-experienced, multi-disciplinary development team with 10 successful product launches offers a turnkey solution to public and private biotechnology and pharmaceutical enterprises allowing flexibility in resource allocation and enhanced return on investment. For more information, please visit www.crozetbiopharma.com.
Latham BioPharm Group (LBG)
Latham BioPharm Group (LBG) is a leading life science consulting company that works with pharmaceutical, biotech, CROs, academia, and medical device/diagnostic companies alike to solve complex business, regulatory, and product development challenges. LBG core services include:
- Product Development: comprehensive functional expertise in vaccines, therapeutics, medical devices, and diagnostics.
- Non-Dilutive Funding: turn-key services from initial positioning within a US Government Agency/Non-Governmental Organization (NGO) to comprehensive proposal development services, to back-end program support, and everything in between.
- Strategic Consulting: full complement of capabilities supporting critical organization decision making, including market research, due diligence/M&A support, and cost modeling.